US Patent Issued to Mapp Biopharmaceutical on May 19 for "Anti-respiratory syncytial virus antibodies, methods of their generation and use" (New Hampshire Inventor)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,611, issued on May 19, was assigned to Mapp Biopharmaceutical Inc. (San Diego).

"Anti-respiratory syncytial virus antibodies, methods of their generation and use" was invented by Laura M. Walker (Lebanon, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are antibodies or antigen binding polypeptides characterized by the ability to neutralize respiratory syncytial virus (RSV). Specifically, the antibodies or antigen binding polypeptides are characterized by high affinity binding to RSV fusion glycoprotein (RSVF). Further provided are methods for their identification, isolation, generation, preparation, and use, as well as the heavy chain a...